The future of the nicotine-addiction market

Lancet

Volumn 362, Issue 9387, 2003, Pages 845-846

  Gray, Nigel ^a   Boyle, Peter ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; NICOTINE; TOXIN;

ADDICTION; CIGARETTE SMOKING; COMMERCIAL PHENOMENA; COMPUTER MODEL; CONSUMER; DRUG INDUSTRY; FUTUROLOGY; HEALTH; HUMAN; INHALER; MARKET; NICOTINE REPLACEMENT THERAPY; NOTE; POLICY; PRIORITY JOURNAL; TOBACCO DEPENDENCE;

EID: 0141741732     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14348-6     Document Type: Note

References (6)

1. Sumner W. Estimating the health consequences of replacing cigarettes with nicotine inhalers. Tob Control. 12:2003;124-132.
2. Editorial. Nicotine use after the year 2000. Lancet 1991; 337: 1191-92.
3. Treatobacco.net. Database & educational resource for treatment of tobacco dependence: Safety. http://www.treatobacco.net/safety/key_findings.cfm (accessed July 31, 2003).
4. Gray N., Zaridze D., Robertson C., Krivosheeva L., Sigacheva N., Boyle P. Variation within global cigarette brands in tar, nicotine, and certain nitrosamines: analytic study. Tob Control. 9:2000;351.
5. Henningfield J.E., Fagerstrom K.O. Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress? Tob Control. 10:2001;253-257.
6. Ramstrom L. Nicotine and public health. 2000;159-178 American Public Health Association, Washington.